Login / Signup

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.

Olivia RuhenNathalie S M LakJanine StutterheimSara G DanielliMathieu ChicardYasmine IddirAlexandra Saint-CharlesVirginia Di PaoloLucia TombolanSusanne Andrea GatzEwa AladowiczPaula ProszekSabri JamalReda StankunaiteDeborah HughesPaul CarterElisa IzquierdoAjla WastiJulia C ChisholmSally L GeorgeErika PaceLouis CheslerIsabelle AertsGaëlle PierronSakina ZaidiOlivier DelattreDidier SurdezAnna KelseyMichael HubankPaolo BonviniGianni BisognoAngela Di GiannataleGudrun SchleiermacherBeat W SchäferGodelieve A M TytgatJanet Shipley
Published in: JCO precision oncology (2022)
Comprehensive ctDNA analysis combining high sensitivity and throughput can identify key molecular drivers in RMS models and patients, suggesting potential as a minimally invasive biomarker. Preclinical assessment of treatments using mouse models and further patient testing through prospective clinical trials are now warranted.
Keyphrases